Tibsovo savings card: as little as $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Tibsovo

We didn’t find one.

Ask your pharmacy for Tibsovo’s cash price, and one or two other pharmacies too.
Tibsovo’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameTibsovo

Authorized genericivosidenib

Regular genericivosidenib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Tibsovo?

The original

–

Brand nameThe maker’s card

TIBSOVO Copay Program (ServierONE)

Savings card from Servier Pharmaceutical

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

Or call 1-844-409-1141.

In the maker’s words

“as little as $0 per prescription…”

From the maker’s offer on servierone-copay.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Tibsovo itself, from the same company, sold without the brand name, and usually for less. For now Tibsovo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TIBSOVO is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with a susceptible IDH1 mutation as detected by an FDA-approved test with:

Newly Diagnosed Acute Myeloid Leukemia (AML)

In combination with azacitidine or as monotherapy for the treatment of newly diagnosed AML in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

Relapsed or refractory AML

For the treatment of adult patients with relapsed or refractory AML.

Relapsed or refractory Myelodysplastic Syndromes (MDS)

For the treatment of adult patients with relapsed or refractory myelodysplastic syndromes.

Locally Advanced or Metastatic Cholangiocarcinoma

For the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma who have been previously treated.

Source: the FDA label for Tibsovo (Servier Pharmaceutical LLC), December 22, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/tibsovo/